Shenker, Bruce J <br/><br/>
PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases.  [electronic resource] 

 -  Current pharmaceutical design  Nov 2011 
 - 3815-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1873-4286 
<br/><br/><label>Standard No.: </label>10.2174/138161211798357926  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bacterial Toxins--immunology<br/>Binding Sites<br/>Cell Degranulation--immunology<br/>Humans<br/>Immunotoxins--immunology<br/>Mast Cells--enzymology<br/>Mastocytosis--drug therapy<br/>Phosphatidylinositol 3-Kinase--immunology<br/>Phosphatidylinositol Phosphates--immunology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Receptor Aggregation--immunology<br/>Receptors, IgE--immunology<br/>Signal Transduction--drug effects